MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    BIOMARKERS OF PARKINSONISM AND POSSIBILITIES OF PREDICTION OF THE COURSE OF PARKINSON’S DISEASE

    D. Akramova, K. Daminova (Tashkent, Uzbekistan)

    Objective: Parkinsonism is one of the most significant problems in clinical neurology, both due to its high prevalence in the world's populations and due to…
  • 2022 International Congress

    Continuous subcutaneous apomorphine infusion for the management of Parkinson’s disease at the end-of-life

    M. Bereau, M. Giffard, AL. Clairet, M. Verin, M. Auffret (Besançon, France)

    Objective: To describe the benefit of continuous subcutaneous apomorphine infusion (CSAI) for terminal care management in 7 PD patients. Background: There are currently no recommendations…
  • 2022 International Congress

    Adrenergic blockers and statins are associated with later age of onset in Parkinson’s disease

    C. Malatt, I. Khatiwala, M. Rangwala, A. Maleki, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)

    Objective: To evaluate the association of anti-hypertensives, non-steroidal anti-inflammatories (NSAIDs), statins, diabetes medications, smoking and family history of idiopathic Parkinson’s disease (iPD) with age of…
  • 2022 International Congress

    Analysis of somatosensory temporal discrimination in essential tremor treated with HIFU VIM thalamotomy: tremoric and lesional effects on the STDT

    CM. Ordás, F. Alonso-Frech, R. Martínez-Fernández, M. Del álamo, JA. Obeso (Móstoles, Spain)

    Objective: To compare somatosensory temporal discrimination threshold (STDT) previously and 4 months after unilateral (left) high intensity focused ultrasound (HIFU) thalamotomy. Secondly, to observe the…
  • 2022 International Congress

    Phase-amplitude coupling between beta power and high frequency oscillations as a sensitive marker of parkinsonian state.

    M. Bočková, M. Lamoš, P. Daniel, M. Baláž, J. Chrastina, I. říha, I. Rektor (Brno, Czech Republic)

    Objective: The aim of this work was to study the potential clinical usefulness of the phase-amplitude coupling (PAC) between beta power and high frequency oscillations (HFO´s).…
  • 2022 International Congress

    Evolution of biochemical and clinical signature of GBA-related Parkinson’s Disease: a 2-year longitudinal study

    M. Avenali, S. Cerri, G. Ongari, C. Pacchetti, C. Tassorelli, EM. Valente, F. Blandini (Pavia, Italy)

    Objective: To evaluate peripheral biochemical markers as well as clinical features of GBA-related Parkinson’s Disease (GBA-PD) subjects over a 2-year follow-up in comparison with NM-PD…
  • 2022 International Congress

    Systematic Literature Review of Key Outcomes Used to Assess Adjunctive Treatments for Parkinson’s Disease

    A. Thach, M. Zichlin, M. Peddle, M. Du, A. Lerner, N. Kirson, A. Bowling, D. Mehta, R. Williams (Marlborough, USA)

    Objective: Understand key efficacy outcomes used to assess adjunctive treatments to carbidopa/levodopa (CD/LD) for Parkinson’s disease (PD). Background: CD/LD is widely considered the most effective…
  • 2022 International Congress

    Detection of Parkinson’s Disease by Analysis of Smooth Pursuit Eye Movements and Machine Learning

    M. Bejani, E. Luque-Buzo, J. Gomez-García, A. Burlaka-Petrash, F. Grandas, J. Godino-Llorente (Madrid, Spain)

    Objective: The present study investigates an automatic method to parameterize smooth pursuit eye movements (SPEM) and to differentiate Parkinson's disease (PD) from controls using machine…
  • 2022 International Congress

    Transcutaneous auricular vagal nerve stimulation has frequency depended propensity to improve gait in Parkinson’s disease – a pilot study

    V. van Midden, Z. Pirtošek, G. Brecl Jakob, M. Kojović (Ljubljana, Slovenia)

    Objective: We used wearable inertion motion sensors (WMS) to compare the acute effects of transcutaneous auricular vagal stimulation (taVNS) at 100Hz (taVNS100), 25Hz (taVNS25), and…
  • 2022 International Congress

    The Spectrum of Movement Disorders Associated With NUS1 Pathogenic Variants

    NE. Mencacci, N. Prakash, E. Gerard, L. Kinsley, BK. Bölsterli, R. Steinfeld, C. Ellis, T. Tropea, T. Bardakjian, A. Lavillaureix, M. Ugolin, C. Thauvin-Robinet, M. Brugger, KM. Riedhammer, T. Opladen, T. Wirth, C. Tranchant, M. Anheim, J. Chelly, BA. Mendelsohn, S. Nandipati, A. Stembridge, HS. Dafsari, H. Zempel, P. Herkenrath, S. Mercimek-Andrews, T. Laut, J. Necpal, R. Jech, M. Zech, G. Trieschmann, S. Berweck, O. Vanakker, D. Gill, F. Gardiner, S. Mohammad, H. Mefford, I. Scheffer, G. Carvill, D. Krainc (Chicago, USA)

    Objective: To explore the phenotype of NUS1-related disorders and determine the spectrum of movement disorders in patients with NUS1 pathogenic variants. Background: A growing body…
  • « Previous Page
  • 1
  • …
  • 584
  • 585
  • 586
  • 587
  • 588
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley